ZA957795B - [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use - Google Patents
[1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and useInfo
- Publication number
- ZA957795B ZA957795B ZA957795A ZA957795A ZA957795B ZA 957795 B ZA957795 B ZA 957795B ZA 957795 A ZA957795 A ZA 957795A ZA 957795 A ZA957795 A ZA 957795A ZA 957795 B ZA957795 B ZA 957795B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- triazolo
- date mar
- substituted
- pox
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK106594 | 1994-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA957795B true ZA957795B (en) | 1996-05-14 |
Family
ID=8100599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA957795A ZA957795B (en) | 1994-09-16 | 1995-09-15 | [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6001832A (de) |
| EP (1) | EP0783504B1 (de) |
| JP (1) | JPH10505601A (de) |
| CN (1) | CN1083842C (de) |
| AT (1) | ATE190616T1 (de) |
| AU (1) | AU706737B2 (de) |
| CA (1) | CA2200055A1 (de) |
| CZ (1) | CZ285248B6 (de) |
| DE (1) | DE69515680T2 (de) |
| DK (1) | DK0783504T3 (de) |
| ES (1) | ES2146769T3 (de) |
| FI (1) | FI971075A (de) |
| GR (1) | GR3033642T3 (de) |
| HU (1) | HUT76810A (de) |
| IL (1) | IL115300A (de) |
| NO (1) | NO308796B1 (de) |
| NZ (1) | NZ292107A (de) |
| PL (1) | PL319176A1 (de) |
| PT (1) | PT783504E (de) |
| RU (1) | RU2149162C1 (de) |
| SK (1) | SK282635B6 (de) |
| WO (1) | WO1996008492A1 (de) |
| ZA (1) | ZA957795B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1285834A (zh) | 1997-11-11 | 2001-02-28 | 小野药品工业株式会社 | 稠合吡嗪化合物 |
| EP2103613B1 (de) * | 2006-12-13 | 2016-02-17 | ASKA Pharmaceutical Co., Ltd. | Chinoxalinderivat |
| ES2612954T3 (es) | 2009-03-05 | 2017-05-19 | Astellas Pharma Inc. | Compuestos de quinoxalina |
| PT2615096T (pt) | 2010-09-07 | 2019-10-15 | Astellas Pharma Inc | Composto de quinoxalina |
| CA2810708A1 (en) * | 2010-09-16 | 2012-03-22 | Hutchison Medipharma Limited | Fused heteroaryls and their uses |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4354027A (en) * | 1980-05-19 | 1982-10-12 | Usv Pharmaceutical Corporation | Triazoloquinoxalin-4-ones |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
| DK162491D0 (da) * | 1991-09-20 | 1991-09-20 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne |
| WO1993020077A1 (en) * | 1992-04-03 | 1993-10-14 | Yamanouchi Pharmaceutical Co., Ltd. | Fused quinoxalinone derivative and pharmaceutical composition containing the same |
| DK31093D0 (de) * | 1993-03-19 | 1993-03-19 | Novo Nordisk As | |
| KR100304177B1 (ko) * | 1993-05-06 | 2001-11-22 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | (1,2,4)트리아졸로(4,3-a)퀴녹살린화합물,이의제조방법및이를함유하는약제학적조성물_ |
-
1995
- 1995-09-12 US US08/809,055 patent/US6001832A/en not_active Expired - Fee Related
- 1995-09-12 PT PT95930409T patent/PT783504E/pt unknown
- 1995-09-12 RU RU97106013A patent/RU2149162C1/ru active
- 1995-09-12 DK DK95930409T patent/DK0783504T3/da active
- 1995-09-12 ES ES95930409T patent/ES2146769T3/es not_active Expired - Lifetime
- 1995-09-12 NZ NZ292107A patent/NZ292107A/xx unknown
- 1995-09-12 DE DE69515680T patent/DE69515680T2/de not_active Expired - Fee Related
- 1995-09-12 PL PL95319176A patent/PL319176A1/xx unknown
- 1995-09-12 WO PCT/DK1995/000364 patent/WO1996008492A1/en not_active Application Discontinuation
- 1995-09-12 CA CA002200055A patent/CA2200055A1/en not_active Abandoned
- 1995-09-12 JP JP8509827A patent/JPH10505601A/ja active Pending
- 1995-09-12 EP EP95930409A patent/EP0783504B1/de not_active Expired - Lifetime
- 1995-09-12 SK SK335-97A patent/SK282635B6/sk unknown
- 1995-09-12 CZ CZ97754A patent/CZ285248B6/cs not_active IP Right Cessation
- 1995-09-12 AT AT95930409T patent/ATE190616T1/de not_active IP Right Cessation
- 1995-09-12 CN CN95195698A patent/CN1083842C/zh not_active Expired - Fee Related
- 1995-09-12 HU HU9701246A patent/HUT76810A/hu unknown
- 1995-09-12 AU AU33807/95A patent/AU706737B2/en not_active Ceased
- 1995-09-14 IL IL11530095A patent/IL115300A/en active IP Right Grant
- 1995-09-15 ZA ZA957795A patent/ZA957795B/xx unknown
-
1997
- 1997-03-14 NO NO971186A patent/NO308796B1/no not_active IP Right Cessation
- 1997-03-14 FI FI971075A patent/FI971075A/fi unknown
-
2000
- 2000-06-08 GR GR20000401329T patent/GR3033642T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL115300A (en) | 2001-06-14 |
| ES2146769T3 (es) | 2000-08-16 |
| WO1996008492A1 (en) | 1996-03-21 |
| CZ75497A3 (en) | 1997-08-13 |
| CN1083842C (zh) | 2002-05-01 |
| AU706737B2 (en) | 1999-06-24 |
| GR3033642T3 (en) | 2000-10-31 |
| IL115300A0 (en) | 1995-12-31 |
| EP0783504B1 (de) | 2000-03-15 |
| PL319176A1 (en) | 1997-08-04 |
| NO308796B1 (no) | 2000-10-30 |
| NZ292107A (en) | 1999-02-25 |
| SK282635B6 (sk) | 2002-10-08 |
| FI971075A0 (fi) | 1997-03-14 |
| ATE190616T1 (de) | 2000-04-15 |
| PT783504E (pt) | 2000-08-31 |
| CA2200055A1 (en) | 1996-03-21 |
| CN1193974A (zh) | 1998-09-23 |
| EP0783504A1 (de) | 1997-07-16 |
| DK0783504T3 (da) | 2000-08-14 |
| RU2149162C1 (ru) | 2000-05-20 |
| HUT76810A (en) | 1997-11-28 |
| JPH10505601A (ja) | 1998-06-02 |
| CZ285248B6 (cs) | 1999-06-16 |
| SK33597A3 (en) | 1998-02-04 |
| FI971075A (fi) | 1997-05-13 |
| US6001832A (en) | 1999-12-14 |
| NO971186D0 (no) | 1997-03-14 |
| DE69515680D1 (de) | 2000-04-20 |
| DE69515680T2 (de) | 2000-10-19 |
| NO971186L (no) | 1997-05-15 |
| AU3380795A (en) | 1996-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960701051A (ko) | 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases) | |
| DE3671370D1 (de) | Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel. | |
| ES2010071A6 (es) | Procedimiento para preparar derivados de isoquinolina. | |
| PL322134A1 (en) | Trisubstituted phenyl derivatives | |
| ATE218860T1 (de) | Verwendung von 3,4-diphenylchromanen zur herstellung eines arzneimittels zur behandlung bzw. vorbeugung des prostatakarzinoms | |
| ZA957795B (en) | [1,2,4]triazolo[4,3-a]quinoxalinone derivatives their preparation and use | |
| PT775143E (pt) | Novos derivados de 3h-2,3-benzodiazepina 3-substituidos sua preparacao e utilizacao | |
| HUP0204282A2 (hu) | Biszszulfonamidok alkalmazása hiperlipidémia kezelésére vagy megelőzésére alkalmas gyógyászati készítmények előállítására | |
| GR3034226T3 (en) | 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia | |
| ATE279925T1 (de) | Verwendung von halofuginon zur herstellung eines medikaments zur vorbeugung von neovaskularisation und zur behandlung bösartiger tumore | |
| MY122667A (en) | Benzofuran derivatives | |
| ZA965749B (en) | Use of allylamines. | |
| NO971187D0 (no) | £1,2,4|triazolo£4,3-a|kinoksalinonderivater, deres fremstilling og anvendelse | |
| ES8705405A1 (es) | Procedimiento de preparar nuevos derivados morfolinicos | |
| PL311296A1 (en) | Derivatives of benzo [f] quinoxalinodione, method of obtaining them and their application in therapeutic agents | |
| IL149308A0 (en) | Use of 1-aminoindan derivatives for treatment of manic disorders |